Randomized placebo-controlled phase III trial of interferon beta-1a in the treatment of disease progression in relapsing MS.

Trial Profile

Randomized placebo-controlled phase III trial of interferon beta-1a in the treatment of disease progression in relapsing MS.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2015

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2015 Results of ADVANCE and MSCRG studies presented at the 1st Congress of the European Academy of Neurology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top